APLT (appliedtherapeutics.com) Market Value

Applied Therapeutics (APLT) specializes in developing drugs for the therapy of rare metabolic disorders. This price chart reflects the impact of scaling Govoresstat sales and partner payments, with a market capitalization of 0.01. Management aims to drive value growth through high-quality research. However, a critical dependence on FDA verdicts creates binary risks that necessitate strict liquidity control.

APLT (Applied Therapeutics) Market Value history from 07/04/2022 to 02/16/2026

Financial and market metric breakdowns for Applied Therapeutics Inc. (APLT)

- market price and analyst price targets:

Price Chart Applied Therapeutics, Inc.|APLT - Forecast Levels Chart

- business market valuation indicators:

Market Value Applied Therapeutics, Inc.|APLT - Total Company Value

- book value of equity indicators:

Accounting Value per Share Applied Therapeutics|APLT - Total Net Assets|Market Value to Book Value Ratio appliedtherapeutics.com|APLT - Company Total Asset Base

- business debt structure and liquidity details:

- net income and valuation multiples indicators:

APLT - Net Profit|Expected Profit Applied Therapeutics|APLT - Price to Earnings Ratio|Forward P/E Multiple Applied Therapeutics, Inc.|APLT - Growth-Adjusted Market Cap to Net Income|Enterprise Value to EBITDA Ratio Applied Therapeutics, Inc.|APLT - Profit before deduction of interest, taxes, depreciation and amortization|Net earnings per share (EPS TTM) Applied Therapeutics|APLT - Net earnings per one share for the last twelve months|Quarterly EPS earnings growth appliedtherapeutics.com|APLT - Earnings per share growth this year|Expected earnings per share growth for next year Applied Therapeutics

Initial company analysis:Applied Therapeutics, Inc. APLT

Original product of Applied Therapeutics Inc.

Market value dynamics directly reflect the market's assessment of operational successes and R&D expenditures. This metric is calculated as the product of the current share price and the total number of shares, determining the business's aggregate capital. For Applied Therapeutics (APLT), the volatility of this metric is driven by geopolitical risks that hinder clinical trials and component logistics. Analyzing the company's total market value allows for the differentiation of temporary drawdowns from a systemic crisis.

Competitors of Applied Therapeutics (APLT)